Retinal Angiomatous Proliferation
3 clinical trials · Condition
◉ Watch Retinal Angiomatous Proliferation
| Record | Firm | Date |
|---|---|---|
| Treat-and-extend Using Aflibercept for Type 3 Neovascularization (NCT04655482) | Kim's Eye Hospital | 2021-02-01 |
| Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy (NCT00470977) | Manhattan Eye, Ear & Throat Hospital | 2007-05-01 |
Track Retinal Angiomatous Proliferation automatically
Every clearance here is in the API, with alerts when new ones post.